Catapulting clopidogrel pharmacogenomics forward

Nat Med. 2011 Jan;17(1):40-1. doi: 10.1038/nm0111-40.
No abstract available

Publication types

  • News
  • Comment

MeSH terms

  • Amino Acid Substitution
  • Aryldialkylphosphatase / genetics
  • Aspirin / therapeutic use
  • Blood Platelets / physiology
  • Clopidogrel
  • Drug Therapy, Combination
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Purinergic P2Y Receptor Antagonists / therapeutic use
  • Stents / adverse effects
  • Thrombosis / drug therapy
  • Thrombosis / etiology
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / pharmacokinetics
  • Ticlopidine / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Clopidogrel
  • Aryldialkylphosphatase
  • PON1 protein, human
  • Ticlopidine
  • Aspirin